Players union votes for HGH testing, new drug rules
By Simon Evans
MIAMI (Reuters) - The NFL Players Association (NFLPA) has approved a new league drug policy following a vote on Friday that will allow testing for human growth hormone (HGH) for the first time, starting this season.
The new policy also raised the threshold for positive results for marijuana and also re-classified the punishment for use of amphetamine during the off-season, the NFLPA said in a statement.
Previously the use of amphetamines were considered performance enhancing drugs by the league but now their off-season use will be penalized as 'substance abuse'.
The policy is 'retroactive' and so allows for some players who were banned for amphetamine use during the most recent off-season to have their suspensions lifted.
The league's website, NFL.com, said that around 20 players could be instantly affected by the deal. Denver Broncos receiver Wes Welker could have his amphetamine ban revoked while Cleveland Browns All-Pro receiver Josh Gordon may see his one year ban cut to 10 games, the website suggested.
The policy must now be finalised between the league and union negotiators although it could take a while to reach an accord after NFL spokesman Greg Aiello admitted barriers remained.
"We have not yet reached an agreement with the union on revisions to our drug programs. There continue to be significant unresolved issues," Aiello said on his verified Twitter account after the NFLPA had earlier hailed the breakthrough deal.
"This is an historic moment for our players and our league," NFLPA President Eric Winston said in a statement after player representatives voted for the changes. Continued...